![]() | Up a level |
McMaster, David, Courtenay, Molly, Santucci, Catherine, Davies, Angharad P, Kirby, Andrew, Seddon, Owen, Price, David A, Barlow, Gavin, Lim, Felicia H, Davies, Bethany S et al (show 12 more authors)
(2020)
Consensus-based antimicrobial resistance and stewardship competencies for UK undergraduate medical students.
JAC-ANTIMICROBIAL RESISTANCE, 2 (4).
dlaa096-.
Sloan, Derek J, McCallum, Andrew D, Schipani, Alessandro, Egan, Deirdre, Mwandumba, Henry C, Ward, Steve A, Waterhouse, David, Banda, Gertrude, Allain, Theresa J, Owen, Andrew ORCID: 0000-0002-9819-7651 et al (show 2 more authors)
(2017)
Genetic Determinants of the Pharmacokinetic Variability of Rifampin in Malawian Adults with Pulmonary Tuberculosis.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 61 (7).
e00210-e00217.
Gafar, Fajri, Wasmann, Roeland E, McIlleron, Helen M, Aarnoutse, Rob E, Schaaf, H Simon, Marais, Ben J, Agarwal, Dipti, Antwi, Sampson, Bang, Nguyen D, Bekker, Adrie et al (show 55 more authors)
(2022)
Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis.
The European respiratory journal, 61 (3).
p. 2201596.
McCallum, Andrew D, Pertinez, Henry E, Chirambo, Aaron P, Sheha, Irene, Chasweka, Madalitso, Malamba, Rose, Shani, Doris, Chitani, Alex, Mallewa, Jane E, Meghji, Jamilah Z et al (show 7 more authors)
(2022)
High Intrapulmonary Rifampicin and Isoniazid Concentrations Are Associated With Rapid Sputum Bacillary Clearance in Patients With Pulmonary Tuberculosis.
CLINICAL INFECTIOUS DISEASES, 75 (9).
pp. 1520-1528.
McCallum, Andrew D, Pertinez, Henry E, Else, Laura J, Dilly-Penchala, Sujan, Chirambo, Aaron P, Sheha, Irene, Chasweka, Madalitso, Chitani, Alex, Malamba, Rose D, Meghji, Jamilah Z et al (show 5 more authors)
(2021)
Intrapulmonary Pharmacokinetics of First-line Anti-tuberculosis Drugs in Malawian Patients With Tuberculosis.
CLINICAL INFECTIOUS DISEASES, 73 (9).
E3365-E3373.
Sloan, Derek
(2013)
Investigation into mycobacterial persistence and early markers of outcome in the treatment of pulmonary tuberculosis.
Doctor of Philosophy thesis, University of Liverpool.
Mzinza, David T, Sloan, Derek J, Jambo, Kondwani C ORCID: 0000-0002-3195-2210, Shani, Doris, Kamdolozi, Mercy, Wilkinson, Katalin A, Wilkinson, Robert J, Davies, Geraint R
ORCID: 0000-0002-3819-490X, Heyderman, Robert S and Mwandumba, Henry C
(2015)
Kinetics of <i>Mycobacterium tuberculosis</i>-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis.
TUBERCULOSIS, 95 (4).
pp. 463-469.
Kloprogge, Frank, Mwandumba, Henry C, Banda, Gertrude, Kamdolozi, Mercy, Shani, Doris, Corbett, Elizabeth L, Kontogianni, Nadia, Ward, Steve, Khoo, Saye H, Davies, Geraint R ORCID: 0000-0002-3819-490X et al (show 1 more authors)
(2020)
Longitudinal Pharmacokinetic-Pharmacodynamic Biomarkers Correlate With Treatment Outcome in Drug-Sensitive Pulmonary Tuberculosis: A Population Pharmacokinetic-Pharmacodynamic Analysis.
OPEN FORUM INFECTIOUS DISEASES, 7 (7).
ofaa218-.
Liu, Yingjun, Pertinez, Henry, Davies, Geraint R ORCID: 0000-0002-3819-490X, Gillespie, Stephen H, Coates, Anthony R and Hua, Yanmin
(2018)
Moxifloxacin Replacement in Contemporary Tuberculosis Drug Regimens Is Ineffective against Persistent<i> Mycobacterium tuberculosis</i> in the Cornell Mouse Model.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 62 (7).
e00190-e00118.
McCallum, Andrew D, Nyirenda, Deborah ORCID: 0000-0002-5867-4687, Lora, Wezzie, Khoo, Saye H
ORCID: 0000-0002-2769-0967, Sloan, Derek J, Mwandumba, Henry C, Desmond, Nicola
ORCID: 0000-0002-2874-8569 and Davies, Geraint R
ORCID: 0000-0002-3819-490X
(2016)
Perceptions of Research Bronchoscopy in Malawian Adults with Pulmonary Tuberculosis: A Cross-Sectional Study.
PLOS ONE, 11 (10).
e0165734-.
Sloan, Derek J, Mwandumba, Henry C, Garton, Natalie J, Khoo, Saye H ORCID: 0000-0002-2769-0967, Butterworth, Anthony E, Allain, Theresa J, Heyderman, Robert S, Corbett, Elizabeth L, Barer, Mike R and Davies, Geraint R
ORCID: 0000-0002-3819-490X
(2015)
Pharmacodynamic Modeling of Bacillary Elimination Rates and Detection of Bacterial Lipid Bodies in Sputum to Predict and Understand Outcomes in Treatment of Pulmonary Tuberculosis.
Clinical Infectious Diseases, 61 (1).
pp. 1-8.
Nyang'wa, Bern-Thomas, Kloprogge, Frank, Moore, David AJ, Bustinduy, Amaya, Motta, Ilaria, Berry, Catherine and Davies, Geraint R ORCID: 0000-0002-3819-490X
(2021)
Population pharmacokinetics and pharmacodynamics of investigational regimens' drugs in the TB-PRACTECAL clinical trial (the PRACTECAL-PKPD study): a prospective nested study protocol in a randomised controlled trial.
BMJ OPEN, 11 (9).
e047185-.
Barr, David A ORCID: 0000-0002-2922-9381, Kamdolozi, Mercy, Nishihara, Yo, Ndhlovu, Victor, Khonga, Margaret, Davies, Geraint R
ORCID: 0000-0002-3819-490X and Sloan, Derek J
(2016)
Serial image analysis of <i>Mycobacterium tuberculosis</i> colony growth reveals a persistent subpopulation in sputum during treatment of pulmonary TB.
TUBERCULOSIS, 98.
pp. 110-115.
Hector, Jonas, Anderson, Suzanne T, Banda, Gertrude, Kamdolozi, Mercy, Jefferys, Laura F, Shani, Doris, Garton, Natalie J, Mwale, Agnes, Jobe, Annie, Davies, Geraint R ORCID: 0000-0002-3819-490X et al (show 1 more authors)
(2017)
TST positivity in household contacts of tuberculosis patients: a case-contact study in Malawi.
BMC INFECTIOUS DISEASES, 17 (1).
259-.
Peloquin, Charles A and Davies, Geraint R ORCID: 0000-0002-3819-490X
(2021)
The Treatment of Tuberculosis.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 110 (6).
pp. 1455-1466.
Pillay, Samantha, Steingart, Karen R, Davies, Geraint R ORCID: 0000-0002-3819-490X, Chaplin, Marty
ORCID: 0000-0002-7097-8704, De Vos, Margaretha, Schumacher, Samuel G, Warren, Rob and Theron, Grant
(2022)
Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 5 (5).
CD014841-.
Pillay, Samantha, Davies, Geraint R ORCID: 0000-0002-3819-490X, Chaplin, Marty
ORCID: 0000-0002-7097-8704, De Vos, Margaretha, Schumacher, Samuel G, Warren, Rob, Steingart, Karen R and Theron, Grant
(2021)
Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin.
Cochrane Database of Systematic Reviews, 2021 (6).
Millard, James D ORCID: 0000-0001-6427-552X, Mackay, Elizabeth A, Bonnett, Laura J
ORCID: 0000-0002-6981-9212 and Davies, Geraint R
ORCID: 0000-0002-3819-490X
(2019)
The impact of inclusion, dose and duration of pyrazinamide (PZA) on efficacy and safety outcomes in tuberculosis: systematic review and meta-analysis protocol.
SYSTEMATIC REVIEWS, 8 (1).
329-.
Muliaditan, Morris, Davies, Geraint R ORCID: 0000-0002-3819-490X, Simonsson, Ulrika SH, Gillespie, Stephen H and Della Pasqua, Oscar
(2017)
The implications of model-informed drug discovery and development for tuberculosis.
DRUG DISCOVERY TODAY, 22 (3).
pp. 481-486.
Imperial, Marjorie Z, Nahid, Payam, Phillips, Patrick PJ, Davies, Geraint R ORCID: 0000-0002-3819-490X, Fielding, Katherine, Hanna, Debra, Hermann, David, Wallis, Robert S, Johnson, John L, Lienhardt, Christian et al (show 1 more authors)
(2019)
A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis (vol 24, 1708, 2018).
NATURE MEDICINE, 25 (1).
p. 190.